• Expertise
  • Ingredient Solutions
  • Applications
  • Resources
    Resources
  • PLT People & Planet
  • About
    About

    Our international network, passionate team of experts and extensive industry knowledge is what sets us apart.

    Seth circle headshot
    Seth Flowerman
    CEO

Dynagenix® Muscle + Joint Formula

Feel Better, Move Better, In Days Not Weeks.
DYNAGENIX-Logo-R

OVERVIEW

Beverage-friendly Dynagenix® Muscle+Joint Formula is clinically demonstrated to provide joint and muscle health benefits in as little as 5 days from start.

5 Days

5 Days

Dynagenix offers fast-acting joint health support

47% Improvement

47% Improvement

Dynagenix offers more joint comfort at 30 days

Up to 47% Less Muscle Soreness

Up to 47% Less Muscle Soreness

Dynagenix reported statistically significantly less soreness than placebo at every recovery point

46% Improvement

46% Improvement

Dynagenix delivers for overall joint health at 30 days

FEATURES & BENEFITS

 

Potent low dose

Five-day efficacy

Reduced post-exercise muscle & joint soreness*

Supports faster, better recovery

47% improvement in joint comfort at 30 days*

47% reduction in joint stiffness at 30 days*

45% improvement in joint function at 30 days*

dynagenix-feature-and-benefit-2

CERTIFICATIONS

Vegan Icon

VEGAN

cert-icons-cert-gluten-free-1

GLUTEN-FREE

cert-icons-cert-water-soluble-1

WATER SOLUBLE

cert-icons-cert-non-gmo-1

NON-GMO

cert-icons-cert-halal-1

HALAL

cert-icons-cert-kosher-1

KOSHER

A high bioavailability, water-soluble Boswellia-based ingredient

The starting point for Dynagenix  – Boswellia serrata – is a plant that produces Indian frankincense. Dynagenix provides a high concentration of AKBA, standardized to 30%.

Boswellia serrata

Sourced from the forests of India, Boswellia has been used in Ayurvedic medicine for thousands of years.


Dynagenix circle

A Sacred Tree

Boswellia serrata are considered sacred by Indian families and given as gifts at weddings.

Rhodiola rosea

Rhodiola rosea is a plant native to remote Arctic climates in Asia, Europe and North America.

rhodiolife-rhodiola-1

 

Exciting Phytochemistry

The root of the plant contains around 140 chemical compounds including phenols, rosavin, rosarin, salidroside and more.

Detail 1

Kale chips cold-pressed put a bird on it mumblecore kogi brooklyn farm-to-table blue bottle yuccie authentic kombucha migas. Literally tilde tacos paleo.

turmeric-curry-moringa-oleifera-ingredient-slendacor

 

Detail 2

Kale chips cold-pressed put a bird on it mumblecore kogi brooklyn farm-to-table blue bottle yuccie authentic kombucha migas. Literally tilde tacos paleo.

RESEARCH

Clinical Science Demonstrates Wide Ranging Musculoskeletal Benefits

Dynagenix has been the subject of two clinical studies that examined various aspects of musculoskeletal support on diverse populations.

Rapid Improvement in Joint Function and Comfort for Everyone

In a 2025 clinical study, 72 men and women (age 40-70) with Grade II osteoarthritis, received either 40 mg/day of Dynagenix or a matching placebo for 30 days. Key outcome measures tested were WOMAC pain, stiffness, and function; a 30-second Chair Stand Test; a 6-minute Walk Test; a Stair Climb Test; and knee flexion and range of motion. Biomarkers of inflammation were also evaluated. Subjects were assessed at baseline, 5, 15, and 30 days.

 

This study showed that Dynagenix delivered statistically significant improvements in joint comfort, stiffness, and function as early as 5 days.

WOMAC Total

Dynagenix subjects showed statistically significant improvements in joint comfort, stiffness, and function as early as 5 days after supplementation, with a 45.6% Improvement in Total WOMAC score at 30 days.

6-min Walk Test – Speed

At Day 30, Dynagenix subjects improved distance walked in 6 minutes by 47 meters, an improvement in walking speed of 8 meters per minute.

30-second Chair Stand Test

Dynagenix subjects significantly improved performance in a 30-Second Chair Stand test – a widely used diagnostic tool of physical function – at 2 weeks

Stair Climb Test

Dynagenix subjects showed a substantial improvement in stair speed of fifty  recreationally active men (age 25-40) were studied for their response to exercise-related muscle and joint soreness. The supplementation period was 10 days with a downhill running exercise on day 7. Recovery was assessed 24, 48, and 72 hours post-exercise, the period in which exercise-induced delayed-onset muscle and joint soreness occur.

 

Active/Sports Performance in a Younger Demographic

In a 2019 clinical trial, 50 recreationally active men (age 25-40) were studied for their response to eccentric exercise-related Delayed-Onset Muscle Soreness (DOMS) using 60mg of Dynagenix versus a placebo. The supplementation period was 10 days with eccentric exercise intervention on day 7, after which recovery was measured on d 8, 9 & 10.


The study demonstrated that daily supplementation of Dynagenix for 10 days results in a significant reduction in muscle soreness during squats (muscle recovery) in healthy male participants over placebo. In parallel, Dynagenix supplementation also improved the recovery of strength (1RM leg extension) and knee range of motion when compared to placebo. Dynagenix supplementation also alleviated the participants' knee soreness (joint recovery).

Muscle Soreness (during squat)
Muscle soreness during unweighted squat increased for both groups, but subjects taking Dynagenix reported statistically significantly less soreness than those taking placebo at every recovery point. Similar data from this study shows walking downstairs is easier too.
Strength on Recovery Day 3
24 out of 25 subjects – 96% taking Dynagenix had full recovery of strength by Recovery Day 3, versus only 10 of 25 using the placebo.
Joint Soreness (during squat) 50%
Joint soreness during unweighted squat increased for both groups, but subjects taking Dynagenix reported statistically significant less soreness than those taking placebo at every recovery point.
Rating of Perceived Exertion

The Borg rating of perceived exertion scale (RPE), a commonly used method scale to assess felt effort, clearly showed statistically significant benefits due to improvements in those taking Dynagenix compared to placebo at all time points.

CLINICAL HIGHLIGHTS

Clinical Study: Rapid Improvement in Joint Function

DGX R CARD crop

72 men and women (age 40-70) with Grade II osteoarthritis, received either 40 mg/day of Dynagenix or placebo for 30 days. The study demonstrated improved joint comfort, stiffness and function starting at 5 days.

 

GET THE RESULTS 

DGX R CARD crop

Clinical Study: Reduced Joint & Muscle Soreness, Faster Recovery

MUSCLE 02

50 recreationally active men (age 25-40) were studied for their response to eccentric exercise-related Delayed-Onset Muscle Soreness (DOMS) using 60mg of Dynagenix versus a placebo.  The study demonstrated reduced joint and muscle soreness and enhanced recovery.

 

GET THE RESULTS

MUSCLE 02

MARKET OPPORTUNITIES

icon-active-con

Active Nutrition

Dynagenix offers a comprehensive solution to post-exercise recovery and promotes the ability to perform at a higher level sooner.

icon-bones

Bone, Joint & Muscle Health

Beyond reducing post-activity muscle and joint soreness, Dynagenix can make everyday tasks easier – like even walking stairs.

APPLICATIONS

app-beverages

BEVERAGES

app-capsules

CAPSULES

app-chews

CHEWS

effervescent icon new

EFFERVESCENTS

app-gummies

GUMMIES

app-powders

POWDERS

app-rtds

RTDS/SHOTS

app-softgels

SOFT GELS

app-stickpacks

STICK PACKS

app-tablets

TABLETS

ORIGIN STORY

Sustainability Combined with Technology Development

Dynagenix is based on a proprietary Boswellia serrata gum resin extract, which you and your customers can be proud of. PLT Boswellia serrata materials are sourced in India from the states of Andhra Pradesh and Madhya Pradesh.

dynagenix-origin-story-1

Long Established Partner

Over the last 25 years, PLT has worked with our innovation partner – Laila Nutraceuticals – to create an environment that can assure not only the highest quality ingredient with proven efficacy, but an ingredient that the people who sell it and buy it can be proud of.

3-1

Responding to the Industry

The Dynagenix product form was developed in response to industry requests for a more organoleptically favorable Boswellia ingredient. Most Boswellia extracts are completely insoluble. They also exhibit a strong odor and bitter taste.

dynagenix-origin-story-3

A Variety of Delivery Systems

The development of this new form was a major technological achievement. Its water solubility and neutral taste properties open the ingredient up to inclusion into a wide range of liquid and solid delivery systems.

dynagenix-origin-story-4

High Bioavailability

One of the surprises of this development process was that the final product showed improved bioavailability compared to the regular Boswellia extracts containing equivalent strength of AKBA.

dynagenix-origin-story-5

QUALITY

Boswellia resin_iStock-1169502987

 

From Harvest to Finished Ingredient


The starting point for Dynagenix – Boswellia serrata – is a plant that produces Indian frankincense. It is also known as Indian olibanum, Salai guggul, and Sallaki in Sanskrit. The plant is native to much of India and the Punjab region that extends into Pakistan. In partnership with Laila, PLT is committed to the safety and fair treatment of the people who harvest Dynagenix. We want to support the long-term health and well-being of the tribal culture and the natural environment upon which it relies.

Every batch of the Dynagenix harvest is assigned a specific batch number, and each batch of finished product is traced to a specific region and set of trees. Dynagenix is tested and must comply with predefined specifications for different parameters at different stages of product manufacturing – from raw materials to finished product. Quality is monitored by a multi-disciplinary organization with dedicated departments for taxonomy (botanical Identification), raw material analysis, chemical analysis, microbiology, and more.

SUSTAINABILITY

Understanding the Difference Makes the Difference


During the fourth quarter of 2021, PLT Health Solutions announced the commencement of a third-party sustainability audit program on Boswellia serrata trees, which serve as the raw material source for some of our most important ingredients. The audit of this India resource was conducted by renowned botanical research consultancy Botanical Liaisons, LLC, and was undertaken to help the nutraceutical industry and non-governmental agencies around the world understand what we and our ingredient innovation partner Laila Nutraceuticals have known for many years: proper stewardship of natural resources and social responsibility toward the communities that support our work are both the right thing to do and good business.


The audit program was a step in PLT’s campaign to document the sustainability of the tree resource. PLT’s Chairman, Paul Flowerman, made field trips to the key production areas in 2018 and 2019 to observe and document the variety of tree populations, methods of natural and forced propagation and the status of the tribal groups involved in the care of the trees and resin production.

AKBA Ingredient_Sustainability Image_1

5loxin-origin-story-1

 

A third audit program was based on a broad range of environmental, cultural and economic parameters. In March 2022 Botanical Liaisons reported to PLT its preliminary conclusions, which included this statement: “It is clear from the information collected from the stakeholders that [sustainability] is supported. Boswellia serrata has several sustainability advantages that prevent over-harvesting of PLT-sourced Boswellia compared to other sources and species of Boswellia.” The report recommended a series of next steps to further evaluate and promote sustainability. 


Subsequently, four important additional developments have added considerable strength to the Boswellia serrata sustainability story:

  1. Authoritative tree survey data from Madhya Pradesh quantified the robustness and sufficiency of the tree resource to provide present and future resin requirements.
  2. CITES (Convention on International Trade in Endangered Species of Wild Fauna and Flora) determined during its November 2022 meeting (COP 19 in Panama City) that no Boswellia species would get added to the CITES Appendix lists. The health of Boswellia serrata, the only species of commercial importance for PLT, was documented, including information about the replenishment of the resource.
  3. AHPA (American Herbal Products Association) convened an expert panel, which has drafted a brochure entitled, “Good Stewardship Harvesting of Boswellia (Boswellia Serrata).” This is a definitive presentation of current best practices.
  4. An important study modeling the impact of significant climate change by 2050 on Boswellia serrata resources predicted that almost all of Madhya Pradesh, the source of 90+% of commercial resin, will remain conducive for a healthy tree population.

These initiatives represent the type of work we do with our PLT360™ initiative. Introduced in 2015, our PLT360 initiative is a business-wide commitment by PLT Health Solutions to develop ingredients that our customers can be confident and proud to supply to their own customers – knowing that these ingredients are safe, of high quality, efficacious and harvested and manufactured sustainably. PLT360 examines every business decision and business process we undertake to be transparent with our operations, build trust with the health & well-being community and, together with them, support healthier, happier lives for the consumers we serve. 

INSIGHTS

dynagenix-quality-1

 

PLT Mobility Solutions

At PLT, we are working on the concept of Mobility Solutions - making these solutions available for people of all ages and walks of life. We’re thinking about athletes who want to perform better and recover faster. We’re thinking about people who have physically demanding jobs who don’t want to or can’t take a day off from work. We’re thinking about anyone who has an active lifestyle who wants to embrace it despite the rigors. And yes, we’re thinking about the global aging population.


PLT Health Solutions’ leading portfolio of mobility support ingredients – based on more than a decade of ongoing research – has been developed to help you deliver innovative products that can capture the attention and the trust of consumers. All of our ingredients are backed by multiple clinical studies – and offer rapid improvements from a low dose - in just about any delivery system you can imagine.

Seth circle headshot

“Dynagenix is exciting because it works at an exceptionally low dose and is water-soluble. This opens up a new world of innovation options for product formulators.”

Seth Flowerman, CEO, PLT Health Solutions 

RESOURCES

Logo
Industry NewsSales Collateral
view
Logo
PLT Health Solutions Unveils Second Clinical Study on Beverage-Friendly Dynagenix® Muscle+Joint Formula Demonstrating Enhanced Mobility & Rapid Joint Comfort within Five Days
October 14, 2025

PLT Health Solutions Unveils Second Clinical Study on Beverage-Friendly Dynagenix® Muscle+Joint Formula Demonstrating Enhanced Mobility & Rapid Joint Comfort within Five Days

Industry NewsPress Releases
read more
Logo
PLT Introduces Dynagenix® Muscle+Joint Formula for Sports & Active Nutrition Applications
June 15, 2020
Breakthrough Ingredient Supports Muscle and Joint Comfort with Enhanced Recovery and Strength After Exercise
Industry NewsPress Releases
read more
Beyond Joint Health - Mobility Solutions for Every Demographic 28686E9C-0345-47E1-B5C6-FB030592A87D
September 27, 2023

Discover new mobility solutions for all demographics with clinically supported botanical ingredients. Watch the webinar for insights and a groundbreaking clinical study.

On-Demand Webinars
read more
Mobility For a Life Better Lived 28686E9C-0345-47E1-B5C6-FB030592A87D
March 30, 2022

Healthy Aging for Every Age is The New Normal

Industry NewsSales Collateral
view